Menarini Silicon Biosystems offers unique rare cell technologies and solutions in liquid biopsy. CELLSEARCH® is the first and only clinically validated blood test cleared by the FDA for detecting and counting Circulating Tumor Cells (CTCs) to aid in managing patients with metastatic breast, prostate, and colorectal cancers when used in conjunction with other clinical methods (full intended use: documents.cellsearchctc.com). DEPArray™ (RUO) is an image-based digital cell-sorting and isolation platform that enables clinical researchers to study rare cells with single-cell precision.
Massimo Scrobogna (Product Manager) email@example.com
Circulating Multiple Myeloma Cell Assay
CellSearch Technology for
CellSearch and DEPArray Liquid Biopsy Workflow